Search Results

There are 28238 results for: content related to: Chapter 79. Metastatic Solid Tumors to Bone

  1. You have free access to this content
    IVth International Conference on Cancer-Induced Bone Diseases: December 7–9, 2003: Adams Mark Hotel Riverwalk, San Antonio, Texas

    Journal of Bone and Mineral Research

    Volume 19, Issue 9, September 2004, Pages: 1559–1600,

    Version of Record online : 1 SEP 2004, DOI: 10.1002/jbmr.5650190923

  2. Bone Metastases: Molecular Mechanisms and Novel Therapeutic Interventions

    Medicinal Research Reviews

    Volume 32, Issue 3, May 2012, Pages: 611–636, Dionysios J. Papachristou, Efthimia K. Basdra and Athanasios G. Papavassiliou

    Version of Record online : 3 SEP 2010, DOI: 10.1002/med.20224

  3. You have free access to this content
    Bone resorption activity of osteolytic metastatic lung and breast cancers

    Journal of Orthopaedic Research

    Volume 22, Issue 6, November 2004, Pages: 1161–1167, Lih-Yuann Shih, Hsin-Nung Shih and Tien-Hsiung Chen

    Version of Record online : 1 JAN 2006, DOI: 10.1016/j.orthres.2003.03.004

  4. Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases

    The Prostate

    Volume 73, Issue 9, June 2013, Pages: 932–940, Sandy R. Larson, Xiaotun Zhang, Ruth Dumpit, Ilsa Coleman, Bryce Lakely, Martine Roudier, Celestia S. Higano, Lawrence D. True, Paul H. Lange, Bruce Montgomery, Eva Corey, Peter S. Nelson, Robert L. Vessella and Colm Morrissey

    Version of Record online : 17 JAN 2013, DOI: 10.1002/pros.22639

  5. You have free access to this content
    Effect of a newly developed bisphosphonate, YH529, on osteolytic bone metastases in nude mice

    International Journal of Cancer

    Volume 77, Issue 2, 17 July 1998, Pages: 279–285, Akira Sasaki, Kazuyuki Kitamura, Rafael E. Alcalde, Toshimitsu Tanaka, Atushi Suzuki, Yohei Etoh and Tomohiro Matsumura

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0215(19980717)77:2<279::AID-IJC18>3.0.CO;2-6

  6. You have full text access to this Open Access content
    Transforming growth factor-β signaling at the tumor–bone interface promotes mammary tumor growth and osteoclast activation

    Cancer Science

    Volume 100, Issue 1, January 2009, Pages: 71–81, Mitsuru Futakuchi, Kalyan C. Nannuru, Michelle L. Varney, Anguraj Sadanandam, Kimihisa Nakao, Kiyofumi Asai, Tomoyuki Shirai, Shin-ya Sato and Rakesh K. Singh

    Version of Record online : 25 NOV 2008, DOI: 10.1111/j.1349-7006.2008.01012.x

  7. You have free access to this content
    Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model

    International Journal of Cancer

    Volume 100, Issue 4, 1 August 2002, Pages: 381–387, Teruo Iwasaki, Mutsuko Mukai, Tohru Tsujimura, Masaharu Tatsuta, Hiroyuki Nakamura, Nobuyuki Terada and Hitoshi Akedo

    Version of Record online : 12 JUN 2002, DOI: 10.1002/ijc.10517

  8. You have free access to this content
    Novel therapeutic targets in myeloma bone disease

    British Journal of Pharmacology

    Volume 171, Issue 16, August 2014, Pages: 3765–3776, S L Webb and C M Edwards

    Version of Record online : 25 JUL 2014, DOI: 10.1111/bph.12742

  9. You have free access to this content
    Pathogenic Role of Connective Tissue Growth Factor (CTGF/CCN2) in Osteolytic Metastasis of Breast Cancer

    Journal of Bone and Mineral Research

    Volume 21, Issue 7, July 2006, Pages: 1045–1059, Tsuyoshi Shimo, Satoshi Kubota, Norie Yoshioka, Soichiro Ibaragi, Sachiko Isowa, Takanori Eguchi, Akira Sasaki and Masaharu Takigawa

    Version of Record online : 15 MAY 2006, DOI: 10.1359/jbmr.060416

  10. You have free access to this content
    Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo

    Journal of Bone and Mineral Research

    Volume 25, Issue 12, December 2010, Pages: 2633–2646, Andrew D Chantry, Debby Heath, Aaron W Mulivor, Scott Pearsall, Marc Baud'huin, Les Coulton, Holly Evans, Nicole Abdul, Eric D Werner, Mary L Bouxsein, Michelle L Key, Jasbir Seehra, Timothy R Arnett, Karin Vanderkerken and Peter Croucher

    Version of Record online : 7 JUN 2010, DOI: 10.1002/jbmr.142

    Corrected by:

    Errata: Erratum: Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo

    Vol. 27, Issue 9, 2036–2037, Version of Record online: 17 AUG 2012

  11. You have free access to this content
    Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer–induced bone cell activity, bone remodeling, and osteolysis

    Journal of Bone and Mineral Research

    Volume 28, Issue 5, May 2013, Pages: 1229–1242, John G Logan, Antonia Sophocleous, Silvia Marino, Morwenna Muir, Valerie G Brunton and Aymen I Idris

    Version of Record online : 17 APR 2013, DOI: 10.1002/jbmr.1847

  12. You have free access to this content
    Evaluating the effects of mixed osteolytic/osteoblastic metastasis on vertebral bone quality in a new rat model

    Journal of Orthopaedic Research

    Volume 30, Issue 5, May 2012, Pages: 817–823, Lisa Wise-Milestone, Margarete K. Akens, Thomas J. Rosol, Seyed-Parsa Hojjat, Marc D. Grynpas and Cari M. Whyne

    Version of Record online : 24 OCT 2011, DOI: 10.1002/jor.21577

  13. You have free access to this content
    ASBMR 31st Annual Meeting MO0001–MO0445

    Journal of Bone and Mineral Research

    Volume 24, Issue S1, 2009, Pages: S370–S496,

    Version of Record online : 16 JUN 2011, DOI: 10.1002/jbmr.5650241305

  14. You have free access to this content
    Molecular mechanisms of osteolytic bone metastases

    Cancer

    Volume 88, Issue S12, 15 June 2000, Pages: 2892–2898, Theresa A. Guise

    Version of Record online : 20 NOV 2000, DOI: 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y

  15. You have free access to this content
    Program & Abstracts

    Journal of Bone and Mineral Research

    Volume 17, Issue S1, September 2002, Pages: S1–S502,

    Version of Record online : 4 AUG 2011, DOI: 10.1002/jbmr.5650170102

  16. Subgroup and cost-benefit analysis of the Finnish multicentre trial of clodronate in multiple myeloma

    British Journal of Haematology

    Volume 87, Issue 4, August 1994, Pages: 725–729, Markku Laakso, Reino Lahtinen, Pekka Virkkunen and Inkeri Elomaa

    Version of Record online : 12 MAR 2008, DOI: 10.1111/j.1365-2141.1994.tb06730.x

  17. You have free access to this content
    Low Cell Motility Induced by hsp27 Overexpression Decreases Osteolytic Bone Metastases of Human Breast Cancer Cells In Vivo

    Journal of Bone and Mineral Research

    Volume 14, Issue 9, September 1999, Pages: 1570–1575, Pierre Lemieux, J. Harvey, Theresa Guise, Mark Dallas, Steffi Oesterreich, Juan Juan Yin, Katri Selander and Suzanne Fuqua

    Version of Record online : 1 SEP 1999, DOI: 10.1359/jbmr.1999.14.9.1570

  18. Chapter 77. Overview of Mechanisms in Cancer Metastases to Bone

    Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism

    Gregory A. Clines, Theresa A. Guise, Pages: 367–370, 2009

    Published Online : 23 DEC 2009, DOI: 10.1002/9780470623992.ch77

  19. You have free access to this content
    Runx2–smad signaling impacts the progression of tumor-induced bone disease

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: 1321–1332, Xuhui Zhang, Jacqueline Akech, Gillian Browne, Stacey Russell, John J. Wixted, Janet L. Stein, Gary S. Stein and Jane B. Lian

    Version of Record online : 5 AUG 2014, DOI: 10.1002/ijc.29094

  20. The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma

    European Journal of Haematology

    Volume 94, Issue 4, April 2015, Pages: 343–354, Zhen Ying Gan, Stephen Fitter, Kate Vandyke, Luen B. To, Andrew C.W. Zannettino and Sally K. Martin

    Version of Record online : 17 SEP 2014, DOI: 10.1111/ejh.12436